美股A股
StockGist
Back
8-K2026-03-11· grok-4-1-fast-non-reasoning

PLRX · Pliant Therapeutics, Inc.

0001746473-26-000039

SEC filing

Summary

Pliant Therapeutics, Inc. issued a press release on March 11, 2026, announcing the Company’s financial results under Item 2.02. The filing includes Exhibit 99.1, the press release, and references Item 9.01 for financial statements and exhibits.

Key takeaways